Notice of Intent To Grant an Exclusive Patent License, 31382 [2018-14400]
Download as PDF
<![CDATA[
31382
Federal Register / Vol. 83, No. 129 / Thursday, July 5, 2018 / Notices
OMB Desk Officer: Nicholas A. Fraser,
email: Nicholas_A._Fraser@
omb.eop.gov.
Once submitted, the request will be
publicly available in electronic format
through www.regino.gov. Follow the
instructions to view the Department of
Commerce collections currently under
review by OMB.
Further information can be obtained
by:
• Email: InformationCollection@
uspto.gov. Include ‘‘0651–0061 copy
request’’ in the subject line of the
message.
• Mail: Marcie Lovett, Records and
Information Governance Division
Director, Office of the Chief Technology
Officer, United States Patent and
Trademark Office, P.O. Box 1450,
Alexandria, VA 22313–1450.
Written comments and
recommendations for the proposed
information collection should be sent on
or before August 6, 2018 to Nicholas A.
Fraser, OMB Desk Officer, via email to
Nicholas_A._Fraser@omb.eop.gov, or by
fax to 202–395–5167, marked to the
attention of Nicholas A. Fraser.
Marcie Lovett,
Director, Records and Information
Governance Division.
[FR Doc. 2018–14384 Filed 7–3–18; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF DEFENSE
Henry Williams,
Acting Air Force Federal Register Liaison
Officer.
Department of the Air Force
[ARH–180613D–PL]
[FR Doc. 2018–14400 Filed 7–3–18; 8:45 am]
Notice of Intent To Grant an Exclusive
Patent License
Department of the Air Force,
Department of Defense.
ACTION: Notice of Intent
AGENCY:
Pursuant to the Bayh-Dole Act
and implementing regulations, the
Department of the Air Force hereby
gives notice of its intent to grant an
exclusive patent license agreement to
Elke Therapeutics, Inc., a domestic
business corporation of the State of New
York, having a place of business at 105
E 34th Street, Unit 198, New York, New
York 10016.
DATES: Written objections must be filed
no later than fifteen (15) calendar days
after the date of publication of this
Notice.
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
Submit written objections to
the Air Force Materiel Command Law
Office, AFMCLO/JAZ, 2240 B Street,
Room 260, Wright-Patterson AFB, OH
ADDRESSES:
16:43 Jul 03, 2018
Jkt 244001
BILLING CODE 5001–10–P
DEPARTMENT OF DEFENSE
Authority: 35 U.S.C. 209; 37 CFR 404.
VerDate Sep<11>2014
45433–7109; Facsimile: (937) 255–3733;
or Email: afmclo.jaz.tech@us.af.mil.
Include Docket No. ARH–180613D–PL
in the subject line of the message.
FOR FURTHER INFORMATION CONTACT: Air
Force Materiel Command Law Office,
AFMCLO/JAZ, 2240 B Street, Rm 260,
Wright-Patterson AFB, OH 45433–7109;
Facsimile: (937) 255–3733; Email:
afmclo.jaz.tech@us.af.mil.
SUPPLEMENTARY INFORMATION: The
Department of the Air Force intends to
grant the exclusive patent license
agreement for the invention described
in:
—U.S. Patent No. 8,575,069, entitled,
‘‘HUMAN PERFORMANCE
BIOMARKER BINDING PEPTIDES
FOR NEUROPEPTIDE Y AND
METHODS OF USING THE SAME,’’
filed 15 January 2013, and issued 5
November 2013.
The Department of the Air Force may
grant the prospective license unless a
timely objection is received that
sufficiently shows the grant of the
license would be inconsistent with the
Bayh-Dole Act or implementing
regulations. A competing application for
a patent license agreement, completed
in compliance with 37 CFR 404.8 and
received by the Air Force within the
period for timely objections, will be
treated as an objection and may be
considered as an alternative to the
proposed license.
Board of Visitors of the U.S. Air Force
Academy; Notice of Federal Advisory
Committee Meeting
Department of the Air Force,
Board of Visitors of the U.S. Air Force
Academy, Department of Defense.
ACTION: Notice of Federal Advisory
Committee Meeting.
AGENCY:
The Department of Defense
(DoD) is publishing this notice to
announce that the following Federal
Advisory Committee meeting of the
Board of Visitors of the U.S. Air Force
Academy will take place.
DATES: Friday July 27, 2018 from 8:30
a.m. to 4:00 p.m. (Mountain Time).
ADDRESSES: United States Air Force
Academy, Blue and Silver Club,
Colorado Springs, CO.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Agenda
0830–0835 ....
0835–0840 ....
0840–0845 ....
0845–0945
0945–1000
1000–1045
1045–1130
1130–1215
....
....
....
....
....
1215–1245
1245–1315
1315–1415
1415–1430
1430–1500
1500–1530
....
....
....
....
....
....
1530–1600 ....
Department of the Air Force
SUMMARY:
Jean
R. Love, (703) 692–7757 (Voice), 703–
693–4244 (Facsimile), jean.r.love.civ@
mail.mil (Email). Mailing address is
SAF/MRM, 1660 Air Force Pentagon,
Washington, DC 20330–1660. Website:
https://www.usafa.edu/about/bov/.
SUPPLEMENTARY INFORMATION: This
meeting is being held under the
provisions of the Federal Advisory
Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended), the
Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.140 and 102–3.150.
Purpose of the Meeting: The purpose
of the meeting is to review morale and
discipline, social climate, athletics,
diversity, curriculum and other matters
relating to the Academy that include a
Superintendent’s update, a
Commandant’s update, a Dean’s update
and Athletic Director’s update.
FOR FURTHER INFORMATION CONTACT:
1600 ..............
Introductions & opening remarks by Designated Federal Officer (Ms. Love)
Call to Order and Agenda
Overview
BoV Chairman: Gen (Ret)
Rice
Chairman’s Opening Comments
Superintendent’s Update
Comfort Break
Commandant’s Update
Dean’s Update
BREAK: Group Photo,
Lunch served
Athletic Director’s Update
CCLD’s Update
Admissions Update
Comfort Break
SAPR Update
Superintendent’s Summary
Remarks
Chairman’s Concluding Remarks
Adjourn (DFO)
Meeting Accessibility: Open to the
public subject to the availability of
space. Registration of members of the
public who wish to attend the meeting
will begin upon publication of this
meeting notice and end three business
days (24 July) prior to the start of the
meeting. All members of the public
must contact Capt. Campos at the phone
number or email listed in the FOR
FURTHER INFORMATION CONTACT. Seating
is limited and is on a first-to-arrive
basis. Attendees will be asked to
provide their name, title, affiliation, and
contact information to include email
address and daytime telephone number
to the POC listed in the FOR FURTHER
INFORMATION CONTACT section. Any
interested person may attend the
meeting, file written comments or
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 83, Number 129 (Thursday, July 5, 2018)]
[Notices]
[Page 31382]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14400]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Air Force
[ARH-180613D-PL]
Notice of Intent To Grant an Exclusive Patent License
Authority: 35 U.S.C. 209; 37 CFR 404.
AGENCY: Department of the Air Force, Department of Defense.
ACTION: Notice of Intent
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Bayh-Dole Act and implementing regulations,
the Department of the Air Force hereby gives notice of its intent to
grant an exclusive patent license agreement to Elke Therapeutics, Inc.,
a domestic business corporation of the State of New York, having a
place of business at 105 E 34th Street, Unit 198, New York, New York
10016.
DATES: Written objections must be filed no later than fifteen (15)
calendar days after the date of publication of this Notice.
ADDRESSES: Submit written objections to the Air Force Materiel Command
Law Office, AFMCLO/JAZ, 2240 B Street, Room 260, Wright-Patterson AFB,
OH 45433-7109; Facsimile: (937) 255-3733; or Email:
[email protected]. Include Docket No. ARH-180613D-PL in the
subject line of the message.
FOR FURTHER INFORMATION CONTACT: Air Force Materiel Command Law Office,
AFMCLO/JAZ, 2240 B Street, Rm 260, Wright-Patterson AFB, OH 45433-7109;
Facsimile: (937) 255-3733; Email: [email protected].
SUPPLEMENTARY INFORMATION: The Department of the Air Force intends to
grant the exclusive patent license agreement for the invention
described in:
--U.S. Patent No. 8,575,069, entitled, ``HUMAN PERFORMANCE BIOMARKER
BINDING PEPTIDES FOR NEUROPEPTIDE Y AND METHODS OF USING THE SAME,''
filed 15 January 2013, and issued 5 November 2013.
The Department of the Air Force may grant the prospective license
unless a timely objection is received that sufficiently shows the grant
of the license would be inconsistent with the Bayh-Dole Act or
implementing regulations. A competing application for a patent license
agreement, completed in compliance with 37 CFR 404.8 and received by
the Air Force within the period for timely objections, will be treated
as an objection and may be considered as an alternative to the proposed
license.
Henry Williams,
Acting Air Force Federal Register Liaison Officer.
[FR Doc. 2018-14400 Filed 7-3-18; 8:45 am]
BILLING CODE 5001-10-P
